Treatment and control of ocular development with cholinergic agonists.

摘要

A composition for the inhibition of the abnormal postnatal axial growth of the eye of a maturing animal which comprise a pharmaceutically effective amount of a cholinergic agonist relatively selective for blocking the cholinergic receptors in cells of the brain, neural tissue and/or neural ganglia but less selective for blocking the cholinergic receptors of the cells of smooth muscles at the front of the eye, said agonist being present in a carrier or diluent suitable for ocular administration. A suitable agonist is pilocarpine, carbamyl choline chloride or an M<1> muscarinic agonist McNeil-A.343.